Skip to main content
Article thumbnail
Location of Repository

Expression of vascular endothelial factor protein in the tumor tissues of patients with Stages I-II ovarian cancer

By V. L. Karapetyan, E. V. Stepanova, A. Yu. Baryshnikov, S. O. Nikogosyan, V. V. Kuznetsov and T. Sh. Tagibova

Abstract

<p>To define tumor markers is presently the most interesting and promising direction for the diagnosis of malignancies. The expression of the major angiogenesis factor vascular endothelial growth factor (VEGF) in primary tumor tissue was studied in ovarian cancer (OC) patients to define the prognostic value of the marker.<br />The study enrolled 48 patients with OC. The immunohistochemical technique was used to examine VEGF expression in the primary tu- mor tissue. The frequency of VEGF expression, which was associated with lower relapse-free survival rates, was found to be high (85.4%) in OC patients (p &gt; 0.05).<br />The tumor expression of the angiogenic factor VEGF was shown to provide prognostic information in early-stage ovarian epithelial cancer.</p

Topics: эпителиальный рак яичников, экспрессия сосудистого эндотелиального фактора роста, прогноз течения заболевания, Gynecology and obstetrics, RG1-991
Publisher: ABV-press
Year: 2010
OAI identifier: oai:doaj.org/article:48a5abb9d4754c16962f50901b1e1fa9
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1999-8627 (external link)
  • https://doaj.org/toc/1994-4098 (external link)
  • http://ojrs.abvpress.ru/ojrs/a... (external link)
  • https://doaj.org/article/48a5a... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.